Rockwell Medical, Inc. (“Rockwell Medical”) is a specialty pharmaceutical company targeting anemia management in end-stage renal disease (ESRD), chronic kidney disease (CKD) and other areas including but not limited to oncology and Total Parental Nutrition. Triferic® is the ONLY FDA-approved product indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients. In addition, Rockwell is an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates (used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream) to dialysis providers and distributors in the U.S. and abroad.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Triferic (ferric pyrophosphate citrate)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):